Independent Franchise Partners LLP Zoetis Inc. Transaction History

Independent Franchise Partners LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$97.98 - $114.28 $10.1 Million - $11.8 Million	-103,053 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$81.56 - $100.67 $79.1 Million - $97.7 Million	-970,425 Reduced 90.4%	103,053 $10.4 Million
Q4 2018 Feb 14, 2019	SELL	$79.28 - $95.27 $2.75 Million - $3.31 Million	-34,704 Reduced 3.13%	1,073,478 $91.8 Million
Q3 2018 Nov 13, 2018	SELL	$83.5 - $93.23 $542,249 - $605,435	-6,494 Reduced 0.58%	1,108,182 $101 Million
Q2 2018 Aug 14, 2018	SELL	$79.9 - $89.2 $11.3 Million - $12.7 Million	-141,969 Reduced 11.3%	1,114,676 $95 Million
Q1 2018 May 15, 2018	SELL	$71.51 - $84.69 $375 Million - $444 Million	-5,238,936 Reduced 80.65%	1,256,645 $105 Million
Q4 2017 Feb 13, 2018	SELL	$63.24 - $72.8 $11.4 Million - $13.1 Million	-180,109 Reduced 2.7%	6,495,581 $468 Million
Q3 2017 Oct 23, 2017	BUY	$59.73 - $65.4 $399 Million - $437 Million	6,675,690	6,675,690 $426 Million

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Independent Franchise Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Independent Franchise Partners LLP with notifications on news.